FDA requires stronger warning for pregnancy treatment terbutaline - Related Stories - AAP SmartBrief
Links shared publicly online about this topic.
- 489total visits
FDA requires stronger warning for pregnancy treatment terbutaline - Related Stories - AAP SmartBrief
The FDA said terbutaline injections, which are used to help pregnant women avoid preterm labor, will carry a boxed warning. Injections should not be administered for longer than three days "because of the potential for serious maternal heart problems and death," the agency said. The FDA also advised
View full resource at smartbrief.com
Tags: Heart, Women's Health, Pregnancy, FDA, American Academy of Pediatrics
Most Recently Shared on February 21, 2011 at 11:46 pm By:
FDA requires stronger warning for pregnancy treatment terbutaline http://sbne.ws/r/6NZB
Advertisement
